MAXCYTE INC's ticker is and the CUSIP is 57777K106. A total of 103 filers reported holding MAXCYTE INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $5,864,935 | -28.5% | 1,074,164 | -14.9% | 0.96% | -31.9% |
| Q3 2022 | $8,207,000 | +27.1% | 1,262,654 | -7.5% | 1.41% | +28.2% |
| Q2 2022 | $6,458,000 | -9.2% | 1,365,423 | +34.2% | 1.10% | +21.3% |
| Q1 2022 | $7,114,000 | -31.8% | 1,017,753 | -0.6% | 0.91% | -17.5% |
| Q4 2021 | $10,437,000 | +74.9% | 1,024,251 | +109.6% | 1.10% | +78.2% |
| Q3 2021 | $5,967,000 | – | 488,673 | – | 0.62% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 1,885,000 | $5,881,200 | 5.55% |
| Vitruvian Partners LLP | 5,043,356 | $15,735,271 | 4.46% |
| Stonepine Capital Management, LLC | 3,761,640 | $11,736,317 | 3.90% |
| Mudita Advisors LLP | 1,390,858 | $4,339,477 | 3.17% |
| RIVER GLOBAL INVESTORS LLP | 1,473,254 | $4,588,359 | 1.07% |
| Casdin Capital, LLC | 1,890,000 | $5,896,800 | 0.65% |
| Portolan Capital Management | 2,143,666 | $6,688,238 | 0.62% |
| Grandeur Peak Global Advisors, LLC | 1,434,819 | $4,476,635 | 0.34% |
| First Light Asset Management, LLC | 1,073,110 | $3,348,103 | 0.32% |
| Granahan Investment Management | 1,975,847 | $6,164,643 | 0.22% |